Sonoma Pharmaceuticals (SNOA) Misses Q3 EPS by 43c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.48), $0.43 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $5.24 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Datavault AI (DVLT) Will Acquire CyberCatch in an All-Cash Transaction
• Reading (RDI) Tops Q2 EPS by 4c